News from regulus therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 21, 2016, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Completes RG-101 Enrollment in Phase II Combination Study

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jan 06, 2016, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Dec 18, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

RG-125(AZD4076), a microRNA Therapeutic Targeting microRNA-103/107 Being Developed for the Treatment of NASH in Patients with Type 2 Diabetes/Pre-Diabetes, Enters Phase I Clinical Development

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Dec 07, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Appoints Joseph P. Hagan Chief Operating Officer

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 12, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Grant of Patents Covering Lead microRNA Therapeutics

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 05, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports Third Quarter 2015 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 03, 2015, 07:15 ET
Regulus Therapeutics Inc. Logo

Regulus Expands Development of RG-101 through Clinical Trial Collaboration with GSK

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Oct 29, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for Third Quarter 2015 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Oct 28, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Achieves All Research Milestones in Collaboration with Biogen to Identify microRNA Biomarkers for Multiple Sclerosis

 Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs,...

Oct 05, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present Additional Preclinical Data Supporting RG-012 as a Novel microRNA Therapeutic in Development for Alport Syndrome at ASN's Kidney Week 2015

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Oct 02, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus to Present Updated Data Supporting RG-101 as Novel microRNA Therapeutic for the Treatment of HCV at The Liver Meeting® 2015 (AASLD)

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Aug 25, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Aug 06, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at the 2015 Wedbush PacGrow Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Aug 04, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jul 28, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 04, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Initiates Phase I Clinical Study of RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 01, 2015, 17:58 ET
Regulus Therapeutics Inc. Logo

Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

May 07, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports First Quarter 2015 Financial Results and Recent Highlights

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 30, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 29, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at the Deutsche Bank 40th Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...